Review



parp1 protein  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress parp1 protein
    Parp1 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/parp1 protein/product/MedChemExpress
    Average 94 stars, based on 28 article reviews
    parp1 protein - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    94
    MedChemExpress parp1 protein
    Parp1 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/parp1 protein/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    parp1 protein - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Sino Biological parp1 enzyme
    Parp1 Enzyme, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/parp1 enzyme/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    parp1 enzyme - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    93
    Boster Bio cleaved parp1
    MCELNs and CELNs elicited apoptosis in TNBC cells. (A)–(B) Flow cytometry detection of apoptosis in MDA-MB-231 cells treated with MCELNs and CELNs for 24 h. (C)–(D) Antagonism of MPA on cell apoptosis induced by MCELNs. (E)–(L) Western blot measured the expression levels of full length <t>PARP1,</t> cleaved PARP1, and cleaved caspase 3 following the treatment of MDA-MB-231 cells with MCELNs for 24 h ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Cleaved Parp1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved parp1/product/Boster Bio
    Average 93 stars, based on 1 article reviews
    cleaved parp1 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Boster Bio full length parp1
    MCELNs and CELNs elicited apoptosis in TNBC cells. (A)–(B) Flow cytometry detection of apoptosis in MDA-MB-231 cells treated with MCELNs and CELNs for 24 h. (C)–(D) Antagonism of MPA on cell apoptosis induced by MCELNs. (E)–(L) Western blot measured the expression levels of full length <t>PARP1,</t> cleaved PARP1, and cleaved caspase 3 following the treatment of MDA-MB-231 cells with MCELNs for 24 h ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Full Length Parp1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/full length parp1/product/Boster Bio
    Average 93 stars, based on 1 article reviews
    full length parp1 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Elabscience Biotechnology protein parp1
    MCELNs and CELNs elicited apoptosis in TNBC cells. (A)–(B) Flow cytometry detection of apoptosis in MDA-MB-231 cells treated with MCELNs and CELNs for 24 h. (C)–(D) Antagonism of MPA on cell apoptosis induced by MCELNs. (E)–(L) Western blot measured the expression levels of full length <t>PARP1,</t> cleaved PARP1, and cleaved caspase 3 following the treatment of MDA-MB-231 cells with MCELNs for 24 h ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Protein Parp1, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/protein parp1/product/Elabscience Biotechnology
    Average 90 stars, based on 1 article reviews
    protein parp1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Sino Biological recombinant human parp1 protein
    ZQJ29 inhibits <t>PARP1</t> activity through direct binding with PARP1. A) PANC‐1 and KP4 cells were treated with varying concentrations of ZQJ29 for 24 h. B,C) Statistical analysis of Figure . D) PANC‐1 and KP4 cells were treated with 5 µM of ZQJ29 for specified periods. E,F) Statistical analysis of Figure . G) Molecular docking model illustrating the binding interaction between ZQJ29 and PARP1. H) Immunofluorescence staining of PARP1 (red) and nuclear DAPI staining (blue) in PANC‐1 and KP4 cells after 24 h treatment with ZQJ29 (0, 1, 2.5, and 5 µ m ). Scale bar: 200 µm. I) Thermal stability analysis of PARP1‐ZQJ29 interaction using CETSA across a temperature gradient (45‐70 °C). (J–K) Statistical analysis of Figure . L) PARP1 stability at 60 °C under treatment with different ZQJ29 concentrations. M,N) Statistical analysis of Figure . O) SPR assay. P) Stability of PARP1 treated with varying pronase/protein ratios. Q,R) Statistical analysis of Figure . S) PARP1 stability under different ZQJ29 concentrations (1:3000). T,U) Statistical analysis of Figure . The data was shown as mean value ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant.
    Recombinant Human Parp1 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human parp1 protein/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    recombinant human parp1 protein - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    MCELNs and CELNs elicited apoptosis in TNBC cells. (A)–(B) Flow cytometry detection of apoptosis in MDA-MB-231 cells treated with MCELNs and CELNs for 24 h. (C)–(D) Antagonism of MPA on cell apoptosis induced by MCELNs. (E)–(L) Western blot measured the expression levels of full length PARP1, cleaved PARP1, and cleaved caspase 3 following the treatment of MDA-MB-231 cells with MCELNs for 24 h ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: Materials Today Bio

    Article Title: Macrophage membrane coating enhances the therapeutic effects of Houttuynia cordata exosome-like nanovesicles against triple-negative breast cancer

    doi: 10.1016/j.mtbio.2025.102604

    Figure Lengend Snippet: MCELNs and CELNs elicited apoptosis in TNBC cells. (A)–(B) Flow cytometry detection of apoptosis in MDA-MB-231 cells treated with MCELNs and CELNs for 24 h. (C)–(D) Antagonism of MPA on cell apoptosis induced by MCELNs. (E)–(L) Western blot measured the expression levels of full length PARP1, cleaved PARP1, and cleaved caspase 3 following the treatment of MDA-MB-231 cells with MCELNs for 24 h ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: The main materials used in this study included P-CHK1, P-ATR, CDK4, CDC25C, P21, γ-H2AX (Abclone), cleaved PARP1, full length PARP1, cleaved caspase 3, BSA (BioFroxx), BCA Protein Concentration Assay Kit (Biyotime Shanghai), SDS-PAGE protein loading buffer (BOSTER, Wuhan), Three-color prestained protein standards (Abclone), Cell Cycle Assay Kit (RedFluorescence) (Biyotime Shanghai), enhanced RIPA lysate (BOSTER, Wuhan), RPMI 1640 medium(Gibco, USA), PKH67 (MedChemExpress, USA), PEG8000 (Chron Chemicals), 5-Fluorouracil (MedChemExpress, USA), and Camptothecin (MedChemExpress, USA).

    Techniques: Flow Cytometry, Western Blot, Expressing

    MCELNs and CELNs elicited apoptosis in TNBC cells. (A)–(B) Flow cytometry detection of apoptosis in MDA-MB-231 cells treated with MCELNs and CELNs for 24 h. (C)–(D) Antagonism of MPA on cell apoptosis induced by MCELNs. (E)–(L) Western blot measured the expression levels of full length PARP1, cleaved PARP1, and cleaved caspase 3 following the treatment of MDA-MB-231 cells with MCELNs for 24 h ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: Materials Today Bio

    Article Title: Macrophage membrane coating enhances the therapeutic effects of Houttuynia cordata exosome-like nanovesicles against triple-negative breast cancer

    doi: 10.1016/j.mtbio.2025.102604

    Figure Lengend Snippet: MCELNs and CELNs elicited apoptosis in TNBC cells. (A)–(B) Flow cytometry detection of apoptosis in MDA-MB-231 cells treated with MCELNs and CELNs for 24 h. (C)–(D) Antagonism of MPA on cell apoptosis induced by MCELNs. (E)–(L) Western blot measured the expression levels of full length PARP1, cleaved PARP1, and cleaved caspase 3 following the treatment of MDA-MB-231 cells with MCELNs for 24 h ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: The main materials used in this study included P-CHK1, P-ATR, CDK4, CDC25C, P21, γ-H2AX (Abclone), cleaved PARP1, full length PARP1, cleaved caspase 3, BSA (BioFroxx), BCA Protein Concentration Assay Kit (Biyotime Shanghai), SDS-PAGE protein loading buffer (BOSTER, Wuhan), Three-color prestained protein standards (Abclone), Cell Cycle Assay Kit (RedFluorescence) (Biyotime Shanghai), enhanced RIPA lysate (BOSTER, Wuhan), RPMI 1640 medium(Gibco, USA), PKH67 (MedChemExpress, USA), PEG8000 (Chron Chemicals), 5-Fluorouracil (MedChemExpress, USA), and Camptothecin (MedChemExpress, USA).

    Techniques: Flow Cytometry, Western Blot, Expressing

    ZQJ29 inhibits PARP1 activity through direct binding with PARP1. A) PANC‐1 and KP4 cells were treated with varying concentrations of ZQJ29 for 24 h. B,C) Statistical analysis of Figure . D) PANC‐1 and KP4 cells were treated with 5 µM of ZQJ29 for specified periods. E,F) Statistical analysis of Figure . G) Molecular docking model illustrating the binding interaction between ZQJ29 and PARP1. H) Immunofluorescence staining of PARP1 (red) and nuclear DAPI staining (blue) in PANC‐1 and KP4 cells after 24 h treatment with ZQJ29 (0, 1, 2.5, and 5 µ m ). Scale bar: 200 µm. I) Thermal stability analysis of PARP1‐ZQJ29 interaction using CETSA across a temperature gradient (45‐70 °C). (J–K) Statistical analysis of Figure . L) PARP1 stability at 60 °C under treatment with different ZQJ29 concentrations. M,N) Statistical analysis of Figure . O) SPR assay. P) Stability of PARP1 treated with varying pronase/protein ratios. Q,R) Statistical analysis of Figure . S) PARP1 stability under different ZQJ29 concentrations (1:3000). T,U) Statistical analysis of Figure . The data was shown as mean value ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant.

    Journal: Advanced Science

    Article Title: Novel Cyano‐Artemisinin Dimer ZQJ29 Targets PARP1 to Induce Ferroptosis in Pancreatic Cancer Treatment

    doi: 10.1002/advs.202501935

    Figure Lengend Snippet: ZQJ29 inhibits PARP1 activity through direct binding with PARP1. A) PANC‐1 and KP4 cells were treated with varying concentrations of ZQJ29 for 24 h. B,C) Statistical analysis of Figure . D) PANC‐1 and KP4 cells were treated with 5 µM of ZQJ29 for specified periods. E,F) Statistical analysis of Figure . G) Molecular docking model illustrating the binding interaction between ZQJ29 and PARP1. H) Immunofluorescence staining of PARP1 (red) and nuclear DAPI staining (blue) in PANC‐1 and KP4 cells after 24 h treatment with ZQJ29 (0, 1, 2.5, and 5 µ m ). Scale bar: 200 µm. I) Thermal stability analysis of PARP1‐ZQJ29 interaction using CETSA across a temperature gradient (45‐70 °C). (J–K) Statistical analysis of Figure . L) PARP1 stability at 60 °C under treatment with different ZQJ29 concentrations. M,N) Statistical analysis of Figure . O) SPR assay. P) Stability of PARP1 treated with varying pronase/protein ratios. Q,R) Statistical analysis of Figure . S) PARP1 stability under different ZQJ29 concentrations (1:3000). T,U) Statistical analysis of Figure . The data was shown as mean value ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant.

    Article Snippet: Recombinant human PARP1 protein (Sino Biological, 11040‐H08B) was immobilized on an activated carboxymethylated 5 (CM5) sensor chip using the amine coupling method.

    Techniques: Activity Assay, Binding Assay, Immunofluorescence, Staining, SPR Assay

    ZQJ29‐induced ferroptosis is PARP1‐dependent. A) PPI network analysis. B) Protein expression in mouse tumor tissues. C) Statistical analysis of Figure . D) Heatmap of protein expression from proteomic data. E) Protein expression in PANC‐1 and KP4 cells treated with varying concentrations of ZQJ29. F,G) Statistical analysis of Figure . H–J) Protein expression in PANC‐1 and KP4 cells treated with ZQJ29 alone or in combination with PARP1 inhibitor (Olaparib), SLC7A11 inhibitor (Erastin), or GPX4 inhibitor (ML‐210). K–P) Statistical analysis of Figure . Q) Expression of PARP1, TP53, SLC7A11, and GPX4 in PANC‐1 and KP4 cells transfected with different PARP1 siRNAs. R,S) Statistical analysis of Figure Q. T,U) Cell viability assessed by CCK‐8 assay in PANC‐1 and KP4 cells transfected with control‐siRNA or PARP1‐siRNA, followed by treatment with ZQJ29 (1 µ m ) for 24 h. The data was shown as mean value ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant.

    Journal: Advanced Science

    Article Title: Novel Cyano‐Artemisinin Dimer ZQJ29 Targets PARP1 to Induce Ferroptosis in Pancreatic Cancer Treatment

    doi: 10.1002/advs.202501935

    Figure Lengend Snippet: ZQJ29‐induced ferroptosis is PARP1‐dependent. A) PPI network analysis. B) Protein expression in mouse tumor tissues. C) Statistical analysis of Figure . D) Heatmap of protein expression from proteomic data. E) Protein expression in PANC‐1 and KP4 cells treated with varying concentrations of ZQJ29. F,G) Statistical analysis of Figure . H–J) Protein expression in PANC‐1 and KP4 cells treated with ZQJ29 alone or in combination with PARP1 inhibitor (Olaparib), SLC7A11 inhibitor (Erastin), or GPX4 inhibitor (ML‐210). K–P) Statistical analysis of Figure . Q) Expression of PARP1, TP53, SLC7A11, and GPX4 in PANC‐1 and KP4 cells transfected with different PARP1 siRNAs. R,S) Statistical analysis of Figure Q. T,U) Cell viability assessed by CCK‐8 assay in PANC‐1 and KP4 cells transfected with control‐siRNA or PARP1‐siRNA, followed by treatment with ZQJ29 (1 µ m ) for 24 h. The data was shown as mean value ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant.

    Article Snippet: Recombinant human PARP1 protein (Sino Biological, 11040‐H08B) was immobilized on an activated carboxymethylated 5 (CM5) sensor chip using the amine coupling method.

    Techniques: Expressing, Transfection, CCK-8 Assay, Control

    The schematic illustration for ZQJ29 targeted PARP1 to activate ferroptosis for anti‐pancreatic cancer.

    Journal: Advanced Science

    Article Title: Novel Cyano‐Artemisinin Dimer ZQJ29 Targets PARP1 to Induce Ferroptosis in Pancreatic Cancer Treatment

    doi: 10.1002/advs.202501935

    Figure Lengend Snippet: The schematic illustration for ZQJ29 targeted PARP1 to activate ferroptosis for anti‐pancreatic cancer.

    Article Snippet: Recombinant human PARP1 protein (Sino Biological, 11040‐H08B) was immobilized on an activated carboxymethylated 5 (CM5) sensor chip using the amine coupling method.

    Techniques: